Cargando…
Assessment of efficacy, safety, and tolerability of 4-n-butylresorcinol 0.3% cream: an Indian multicentric study on melasma
INTRODUCTION: Melasma is one of the commonly reported pigmentory disorders in the Indian population. Numerous therapeutic modalities are available. However, very few have produced complete satisfactory response. 4-n-Butylresorcinol 0.3% cream has recently been introduced in India as a new hypopigmen...
Autores principales: | Madan Mohan, NT, Gowda, Adarsh, Jaiswal, Ashok Kumar, Sharath Kumar, BC, Shilpashree, P, Gangaboraiah, Bilugumba, Shamanna, Manjula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725640/ https://www.ncbi.nlm.nih.gov/pubmed/26855596 http://dx.doi.org/10.2147/CCID.S89451 |
Ejemplares similares
-
The treatment of melasma by silymarin cream
por: Altaei, Tagreed
Publicado: (2012) -
A cream of herbal mixture to improve melasma
por: Zhang, Qiongyu, et al.
Publicado: (2019) -
Granuloma faciale: An unusual diascopic finding
por: Ravikiran, Shilpashree P., et al.
Publicado: (2016) -
4-n-Butylresorcinol-Based Linear and Graft Polymethacrylates for Arbutin and Vitamins Delivery by Micellar Systems
por: Odrobińska, Justyna, et al.
Publicado: (2020) -
Comparison of the efficacy of intradermal injected tranexamic acid vs hydroquinone cream in the treatment of melasma
por: Pazyar, Nader, et al.
Publicado: (2019)